Mayo Clinic Q&A: Cardiac Risks of Off-Label Drugs to Treat COVID-19

  • 1 video | 15m 50s
A study published recently in Mayo Clinic Proceedings details information about potential cardiac side effects when using off-label drugs to treat COVID-19. Off-label means the drug has been approved by the Food and Drug Administration to treat a different condition. Some of the off-label drugs being used to treat COVID-19 have a risk of sudden cardiac arrest and death. (Published 04/08/2020)